Target intelligence / Profile preview

Streptococcus pneumoniae capsular polysaccharide serotype 6B (CPS 6B)

Target
CPS 6B
Molecular classification
Polysaccharide, Bacterial surface antigen
01

Overview

The Streptococcus pneumoniae capsular polysaccharide serotype 6B is a complex carbohydrate polymer that encapsulates the bacterium, serving as its primary virulence factor. This polysaccharide structure protects the pathogen from the host's immune system by inhibiting phagocytosis and preventing complement-mediated lysis. Due to its significant role in causing invasive pneumococcal diseases such as pneumonia, meningitis, and sepsis, it is utilized as a key antigen in various pneumococcal vaccines. These vaccines, including conjugate (PCV) and polysaccharide (PPSV) formulations, trigger the production of specific antibodies that bind to the 6B capsule, allowing for opsonization and subsequent clearance by the host's immune system. Monitoring the efficacy of these interventions typically involves measuring serotype-specific IgG levels and opsonophagocytic activity.

Other names
Pneumococcal polysaccharide serotype 6BPn6B PSStreptococcus pneumoniae type 6B capsular antigenPneumococcal capsular polysaccharide 6B
02

Mechanism of action

Induction of serotype-specific humoral immunity, specifically opsonophagocytic antibodies that facilitate bacterial recognition and destruction by immune cells.

03

Biological functions

Bacterial virulenceImmune evasionAntiphagocytic activity
04

Disease associations

PneumoniaMeningitisBacteremiaOtitis mediaInfection
05

Safety considerations

Injection site reactionsHypersensitivitySerotype replacement (emergence of non-vaccine serotypes)
06

Interacting drugs

Pneumococcal 13-valent conjugate vaccine (Prevnar 13)

3 more in the full profile.

07

Biomarkers

Serotype-specific IgG antibody concentrationOpsonophagocytic activity (OPA) titer

Source types: Peer-reviewed publication. Sources are available to Gosset users. Log in to see them.

Beyond the preview

Go deeper on Streptococcus pneumoniae capsular polysaccharide serotype 6B (CPS 6B).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Streptococcus pneumoniae capsular polysaccharide serotype 6B (CPS 6B).

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call